Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/1998
05/26/1998US5756118 Enhanced skin penetration system for improved topical delivery of drugs
05/26/1998US5756090 Oxygen activatable formulations for disinfection or sterilization
05/26/1998US5755968 Dialysis system and method for removing toxic matter from the serum of the large intestine
05/22/1998WO1998021584A1 Combinatorial process for preparing thiazolidinone libraries
05/22/1998WO1998021359A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998WO1998021345A1 Hsv/aav hybrid amplicon vectors
05/22/1998WO1998021331A1 Human breast tumor-specific proteins
05/22/1998WO1998021324A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
05/22/1998WO1998021243A1 Method and novel compounds for use therein
05/22/1998WO1998021229A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998WO1998020897A1 Modulation of map kinase phosphatase 1 (mkp-1)
05/22/1998WO1998020891A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998WO1998020883A1 Use of pvp or povidone for reducing bowel distension
05/22/1998WO1998020870A1 Improved treatment of migraine headache
05/22/1998WO1998020868A1 Guanylhydrazones useful for treating diseases associated with t cell activation
05/22/1998WO1998020867A1 Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
05/22/1998WO1998020852A1 Pharmaceutical compositions containing kukui nut oil
05/22/1998WO1998020736A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES
05/22/1998WO1998015277A3 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents
05/22/1998CA2271951A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
05/22/1998CA2271777A1 Hsv/aav hybrid amplicon vectors
05/22/1998CA2271147A1 Combinatorial process for preparing thiazolidinone libraries
05/22/1998CA2270943A1 Use of pvp or povidone for reducing bowel distension
05/22/1998CA2270910A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998CA2270634A1 Methods and compositions for stimulating neurite growth
05/22/1998CA2270158A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998CA2270156A1 Human breast tumor-specific proteins
05/21/1998CA2216616A1 Cayae1
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0843009A2 A human mytrophin clone hsabh01
05/20/1998EP0842946A1 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842276A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842267A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
05/20/1998EP0842189A1 Early onset alzheimer's disease gene and gene products
05/20/1998EP0841949A2 Saccharide conjugates
05/20/1998EP0841947A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
05/20/1998EP0841946A1 Methods for treatment of allergic asthma
05/20/1998EP0841939A1 Therapeutic agents and autoimmune diseases
05/20/1998EP0841921A2 Use of fluconazole for inhibiting the growth of cancers
05/20/1998EP0841914A2 Use of griseofulvin for inhibiting the growth of cancers
05/20/1998EP0841910A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS
05/20/1998EP0841909A2 Use of alicyclic diamines as immunomodulators
05/20/1998EP0841907A1 Use of agonists or antagonists of p 2? purinoceptors for the prevention of glutamate-evoked cytotoxicity
05/20/1998EP0841904A1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
05/20/1998EP0841903A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
05/20/1998EP0841900A1 Method of detecting lung disease
05/20/1998EP0542860B1 Immunosuppressive compositions
05/20/1998CN1182454A DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
05/20/1998CN1182371A Formulations for lipophilic compounds
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182366A Use of nitric oxide donors or nitric oxide inhibitors for regulation cervical dilatation and extensiblity
05/19/1998US5753713 Method for promoting hair growth
05/19/1998US5753702 Inhibitors of neutrophil adhesion, antiinflammatory
05/19/1998US5753681 Treatment and prophylaxis of pancreatitis
05/19/1998US5753651 Method of modifying angiotensin receptor activity for mediation of pain
05/19/1998US5753641 Method of treatment for benign prostatic hyperplasia
05/19/1998US5753630 Method for treating and inhibiting gastric and duodenal ulcers
05/19/1998US5753622 Use of epidermal growth factor as a gastrointestinal therapeutic agent
05/19/1998US5753620 Antagonist to tumor necrosis factor and interleukins
05/19/1998US5753611 Pharmaceutical composition having site-specific delivery
05/19/1998US5753480 Cysteinyl tRNA synthetase polynucleotides of streptococcus
05/19/1998US5753479 Genetic enginnering
05/19/1998US5753247 Method of treating fungal infections
05/19/1998US5753237 Method for augmenting immunological responses
05/19/1998US5753230 Methods and compositions useful for inhibition of angiogenesis
05/14/1998WO1998020161A1 Methods for identifying genes essential to the growth of an organism
05/14/1998WO1998020142A1 Notch
05/14/1998WO1998020137A1 Human squalene epoxidase
05/14/1998WO1998020128A1 Human regulator of g-protein signaling - (hrgs)
05/14/1998WO1998020127A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/14/1998WO1998020124A2 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998WO1998020117A1 Prostate-specific kallikrein
05/14/1998WO1998020110A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF
05/14/1998WO1998020109A1 Pressure-mediated intracellular delivery of molecules or microparticles
05/14/1998WO1998020040A1 Novel histamine h2 receptor
05/14/1998WO1998020027A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
05/14/1998WO1998020022A1 Soluble proteins
05/14/1998WO1998019701A1 Methods for promoting wound healing and treating transplant-associated vasculopathy
05/14/1998WO1998019700A1 Treatment of inner ear hair cells
05/14/1998WO1998019699A1 Use of growth hormone or a growth hormone secretagogue for promoting bone formation
05/14/1998WO1998019696A1 Hepatocyte growth factor antagonists
05/14/1998WO1998019690A1 Method for treating alzheimer's disease
05/14/1998WO1998019689A1 Novel coding sequences
05/14/1998WO1998019680A1 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
05/14/1998WO1998019678A1 Improved intraocular irrigating solution containing a polyamine antagonist
05/14/1998WO1998019672A1 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/14/1998WO1998019670A2 Combination therapy of hepatitis c infections
05/14/1998WO1998019669A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998010757A3 The use of functional N-methyl-D-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
05/14/1998WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor
05/14/1998WO1998001440A3 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
05/14/1998WO1997044054A3 Type-2 chemokine binding proteins and methods of use therefor
05/14/1998CA2593733A1 A method for treating tension-type headache
05/14/1998CA2270909A1 Novel histamine h2 receptor
05/14/1998CA2270867A1 Hepatocyte growth factor antagonists
05/14/1998CA2270780A1 Method for treating alzheimer's disease
1 ... 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 ... 1151